Epilepsy Research
Volume 91, Issue 1 , Pages 1-9 , September 2010

RCTs with new antiepileptic drugs in children: A systematic review of monotherapy studies and their methodology

  • Amerins Weijenberg

      Affiliations

    • Department of Neurology, University Medical Centre Groningen, University of Groningen, P.O. Box 30 001, 9700 RB Groningen, The Netherlands
    • ,
  • Martin Offringa

      Affiliations

    • Department of Paediatric Clinical Epidemiology, Emma Children's Hospital, Academic Medical Centre, University of Amsterdam, P.O. Box 22660, 1100 DD Amsterdam, The Netherlands
    • ,
  • Oebele F. Brouwer

      Affiliations

    • Department of Neurology, University Medical Centre Groningen, University of Groningen, P.O. Box 30 001, 9700 RB Groningen, The Netherlands
    • ,
  • Petra M.C. Callenbach

      Affiliations

    • Department of Neurology, University Medical Centre Groningen, University of Groningen, P.O. Box 30 001, 9700 RB Groningen, The Netherlands
    • Corresponding Author InformationCorresponding author. Tel.: +31 50 3612430; fax: +31 50 3611707.

Received 15 March 2010 ,Revised 17 June 2010 ,Accepted 4 July 2010.

References 

  1. Aikia M, Jutila L, Salmenpera T, Mervaala E, Kalviainen R. Comparison of the cognitive effects of tiagabine and carbamazepine as monotherapy in newly diagnosed adult patients with partial epilepsy: pooled analysis of two long-term, randomized, follow-up studies. Epilepsia. 2006;47:1121–1127
  2. Arroyo S, Dodson WE, Privitera MD, Glauser TA, Naritoku DK, Dlugos DJ, et al. Randomized dose-controlled study of topiramate as first-line therapy in epilepsy. Acta Neurol. Scand. 2005;112:214–222
  3. Arroyo S, Squires L, Wang S, Twyman R. Topiramate: effective as monotherapy in dose-response study in newly diagnosed epilepsy. Epilepsia. 2002;43(Suppl. 7):241
  4. Beydoun A, Sachdeo RC, Kutluay E, McCague K, D'Souza J. Sustained efficacy and long-term safety of oxcarbazepine: one-year open-label extension of a study in refractory partial epilepsy. Epilepsia. 2003;44:1160–1165
  5. Beydoun A, Sachdeo RC, Rosenfeld WE, Krauss GL, Sessler N, Mesenbrink P, et al. Oxcarbazepine monotherapy for partial-onset seizures: a multicenter, double-blind, clinical trial. Neurology. 2000;54:2245–2251
  6. Biton V, Levisohn P, Hoyler S, Vuong A, Hammer AE. Lamotrigine versus valproate monotherapy-associated weight change in adolescents with epilepsy: results from a post hoc analysis of a randomized, double-blind clinical trial. J. Child Neurol. 2003;18:133–139
  7. Biton V, Mirza W, Montouris G, Vuong A, Hammer AE, Barrett PS. Weight change associated with valproate and lamotrigine monotherapy in patients with epilepsy. Neurology. 2001;56:172–177
  8. Bourgeois B, Brown LW, Pellock JM, Buroker M, Greiner M, Garofalo EA, et al. Gabapentin (Neurontin) monotherapy in children with benign childhood epilepsy with centrotemporal spikes (BECTS): a 36-week, double-blind, placebo-controlled study. Epilepsia. 1998;39(Suppl. 6):163
  9. Callenbach PMC, Arts WFM, ten Houten R, Augustijn P, Gunning WB, Peeters EAJ, et al. Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study. Eur. J. Paediatr. Neurol. 2008;12:321–327
  10. Carpay JA, Aldenkamp AP, van Donselaar CA. Complaints associated with the use of antiepileptic drugs: results from a community-based study. Seizure. 2005;14:198–206
  11. Chadwick DW, Anhut H, Greiner MJ, Alexander J, Murray GH, Garofalo EA, et al. A double-blind trial of gabapentin monotherapy for newly diagnosed partial seizures. International Gabapentin Monotherapy Study Group 945-77. Neurology. 1998;51:1282–1288
  12. Chung AM, Eiland LS. Use of second-generation antiepileptic drugs in the pediatric population. Paediatr. Drugs. 2008;10:217–254
  13. Commission on Classification and Terminology of the International League Against Epilepsy . Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia. 1981;22:489–501
  14. Commission on Classification and Terminology of the International League Against Epilepsy . Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia. 1989;30:389–399
  15. Coppola G, Auricchio G, Federico R, Carotenuto M, Pascotto A. Lamotrigine versus valproic acid as first-line monotherapy in newly diagnosed typical absence seizures: an open-label, randomized, parallel-group study. Epilepsia. 2004;45:1049–1053
  16. Coppola G, Franzoni E, Verrotti A, Garone C, Sarajlija J, Felicia Operto F, et al. Levetiracetam or oxcarbazepine as monotherapy in newly diagnosed benign epilepsy of childhood with centrotemporal spikes (BECTS): an open-label, parallel group trial. Brain Dev. 2007;29:281–284
  17. Duchowny M, Pellock JM, Graf WD, Billard C, Gilman J, Casale E, et al. A placebo-controlled trial of lamotrigine add-on therapy for partial seizures in children. Lamictal Pediatric Partial Seizure Study Group. Neurology. 1999;53:1724–1731
  18. Dulac O. Issues in paediatric epilepsy. Acta Neurol. Scand. 2005;(Suppl. 182):9–11
  19. European Medicines Agency (Committee for Medicinal Products for Human use) . Guideline on Data Monitoring Committees. EMEA/CHMP/EWP/5872/03 Corr; 2005;
  20. Fernandes RM, van der Lee JH, Offringa M. A systematic review of the reporting of Data Monitoring Committees’ roles, interim analysis and early termination in pediatric clinical trials. BMC Pediatr. 2009;9:77
  21. Frank LM, Enlow T, Holmes GL, Manasco P, Concannon S, Chen C, et al. Lamictal (lamotrigine) monotherapy for typical absence seizures in children. Epilepsia. 1999;40:973–979
  22. Gilliam FG, Veloso F, Bomhof MA, Gazda SK, Biton V, Ter Bruggen JP, et al. A dose-comparison trial of topiramate as monotherapy in recently diagnosed partial epilepsy. Neurology. 2003;60:196–202
  23. Glauser TA, Dlugos DJ, Dodson WE, Grinspan A, Wang S, Wu SC. Topiramate monotherapy in newly diagnosed epilepsy in children and adolescents. J. Child Neurol. 2007;22:693–699
  24. Glauser TA, Nigro M, Sachdeo R, Pasteris LA, Weinstein S, Abou-Khalil B, et al. Adjunctive therapy with oxcarbazepine in children with partial seizures. The Oxcarbazepine Pediatric Study Group. Neurology. 2000;54:2237–2244
  25. Guerreiro MM, Vigonius U, Pohlmann H, de Manreza ML, Fejerman N, Antoniuk SA, et al. A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in children and adolescents with epilepsy. Epilepsy Res. 1997;27:205–213
  26. Huang TS, Zhu JL, Li B, Hu Y, Chen L, Liao JX. Valproic acid versus lamotrigine as a monotherapy for absence epilepsy in children. Zhongguo Dang. Dai Er. Ke. Za Zhi. 2009;11:653–655
  27. Ingwersen SH, Pedersen PC, Groes L, Nielsen KK, Aarons L. Population pharmacokinetics of tiagabine in epileptic patients on monotherapy. Eur. J. Pharm. Sci. 2000;11:247–254
  28. Jensen PK. Felbamate in the treatment of refractory partial-onset seizures. Epilepsia. 1993;34(Suppl. 7):S25–S29
  29. Kang HC, Eun BL, Wu LC, Ku MH, Kim JS, Wook KD, et al. The effects on cognitive function and behavioral problems of topiramate compared to carbamazepine as monotherapy for children with benign rolandic epilepsy. Epilepsia. 2007;48:1716–1723
  30. Lindberger M, Alenius M, Frisen L, Johannessen SI, Larsson S, Malmgren K, et al. Gabapentin versus vigabatrin as first add-on for patients with partial seizures that failed to respond to monotherapy: a randomized, double-blind, dose titration study. GREAT Study Investigators Group. Gabapentin in Refractory Epilepsy Add-on Treatment. Epilepsia. 2000;41:1289–1295
  31. Nieto-Barrera M, Brozmanova M, Capovilla G, Christe W, Pedersen B, Kane K, et al. A comparison of monotherapy with lamotrigine or carbamazepine in patients with newly diagnosed partial epilepsy. Epilepsy Res. 2001;46:145–155
  32. Noachtar S, Andermann E, Meyvisch P, Andermann F, Gough WB, Schiemann-Delgado J. Levetiracetam for the treatment of idiopathic generalized epilepsy with myoclonic seizures. Neurology. 2008;70:607–616
  33. Perucca E, Tomson T. Monotherapy trials with the new antiepileptic drugs: study designs, practical relevance and ethical implications. Epilepsy Res. 1999;33:247–262
  34. Privitera MD, Brodie MJ, Mattson RH, Chadwick DW, Neto W, Wang S. Topiramate, carbamazepine and valproate monotherapy: double-blind comparison in newly diagnosed epilepsy. Acta Neurol. Scand. 2003;107:165–175
  35. Resendiz-Aparicio JC, Rodriguez-Rodriguez E, Contreras-Bernal J, Ceja-Moreno H, Barragan-Perez E, Garza-Morales S, et al. A randomised open trial comparing monotherapy with topiramate versus carbamazepine in the treatment of paediatric patients with recently diagnosed epilepsy. Rev. Neurol. 2004;39:201–204
  36. Sachdeo R, Beydoun A, Schachter S, Vazquez B, Schaul N, Mesenbrink P, et al. Oxcarbazepine (Trileptal) as monotherapy in patients with partial seizures. Neurology. 2001;57:864–871
  37. Sankar R, Ramsay E, McKay A, Hulihan J, Wiegand F. A multicenter, outpatient, open-label study to evaluate the dosing, effectiveness, and safety of topiramate as monotherapy in the treatment of epilepsy in clinical practice. Epilepsy Behav. 2009;15:506–512
  38. Schachter SC, Vazquez B, Fisher RS, Laxer KD, Montouris GD, Combs-Cantrell DT, et al. Oxcarbazepine: double-blind, randomized, placebo-control, monotherapy trial for partial seizures. Neurology. 1999;52:732–737
  39. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA. 1995;273:408–412
  40. Sethi A, Chandra D, Puri V, Mallika V. Gabapentin and lamotrigine in Indian patients of partial epilepsy refractory to carbamazepine. Neurol. India. 2002;50:359–363
  41. Siegel H, Kelley K, Stertz B, Reeves-Tyer P, Flamini R, Malow B, et al. The efficacy of felbamate as add-on therapy to valproic acid in the Lennox-Gastaut syndrome. Epilepsy Res. 1999;34:91–97
  42. Trudeau V, Myers S, LaMoreaux L, Anhut H, Garofalo E, Ebersole J. Gabapentin in naive childhood absence epilepsy: results from two double-blind, placebo-controlled, multicenter studies. J. Child Neurol. 1996;11:470–475
  43. Uijl SG, Uiterwaal CS, Aldenkamp AP, Carpay JA, Doelman JC, Keizer K, et al. A cross-sectional study of subjective complaints in patients with epilepsy who seem to be well-controlled with anti-epileptic drugs. Seizure. 2006;15:242–248
  44. Verrotti A, Cerminara C, Domizio S, Mohn A, Franzoni E, Coppola G, et al. Levetiracetam in absence epilepsy. Dev. Med. Child Neurol. 2008;50:850–853
  45. Wheless JW, Neto W, Wang S. Topiramate, carbamazepine, and valproate monotherapy: double-blind comparison in children with newly diagnosed epilepsy. J. Child Neurol. 2004;19:135–141

PII: S0920-1211(10)00166-X

doi: 10.1016/j.eplepsyres.2010.07.004

Epilepsy Research
Volume 91, Issue 1 , Pages 1-9 , September 2010

Article Tools